Expert Take
Equitable Access to GLP-1 Receptor Agonists—Essential but Not Accessible
Journal of the American Medical Association
By Thomas J. Bollyky and Chloe Searchinger
Thomas J. Bollyky
Archive
725 results
- Featuring Thomas J. Bollyky
- Featuring Thomas J. Bollyky
Expert TakeThe Future of Global Health: Themes and Thorny Questions
Think Global Health
By Stephanie Psaki, Anya Hirschfeld and Thomas J. Bollyky- Expert TakeBy Thomas J. Bollyky and Joseph L. Dieleman
- Expert TakeBy Thomas J. Bollyky, Prashant Yadav, Rush Doshi, Paul Friedrichs and Victor Suarez
Featuring Thomas J. Bollyky
By Thomas J. BollykyCongress Weighs FDA Reforms to Boost U.S. Drug Development
Washington Post
Featuring Thomas J. Bollyky
The Biotech Race: Can America Stay Ahead of China?
Washington Post
Featuring Thomas J. BollykyWhy Ebola Came Back — and a Warning for the Next Pandemic
Financial Times
Featuring Thomas J. Bollyky- Featuring Thomas J. Bollyky and Prashant Yadav
36:40PodcastThe President’s Inbox
ReportBy Thomas J. Bollyky, Rush Doshi, Prashant Yadav, Olivia Kosloff and Elena Every- Workshop
- Featuring Thomas J. Bollyky
Expert TakeTracking the "America First" Bilateral Health Agreements
Think Global Health
By Thomas J. Bollyky, Anya Hirschfeld, Allison Krugman, Stephanie Psaki and Joseph L. Dieleman- Expert Take
Improving the Resilience of the Pharmaceutical Supply Chain Through Make-Buy-Invest Strategic Actions: A National Security Perspective
National Academies of Science, Engineering, and Medicine
By Thomas J. Bollyky - Expert Take
The WHO Could Mend Its U.S. Breakup By Playing the Waiting Game
Think Global Health
By Thomas J. Bollyky and Elena Every - Featuring Thomas J. Bollyky
By Ivana Saric and Thomas J. Bollyky
By Inu Manak, Edward Alden, Thomas J. Bollyky, Chris McGuire and Chloe Searchinger
